Stroke:介入治疗大血管闭塞性卒中是有效的(独立于静脉溶栓)

2016-07-24 phylis 译 MedSci原创

背景:在过去的十年,紧急大血管闭塞的血管内介入治疗(ELVO)发展迅速。是否静脉溶栓(IVT)预处理对ELVO患者功能预后有显著的影响仍不清楚。方法:研究对所有评估血管内治疗(ET)对急性缺血性卒中的疗效的随机对照试验,进行了系统的综述和荟萃分析。研究者按照IVT预治疗进行分层,进行的混合效应亚组分析报告,对ET(与标准治疗)与3功能结果的相关性的OR值。结果:纳入六项随机对照试验,包括1916

背景:在过去的十年,紧急大血管闭塞的血管内介入治疗(ELVO)发展迅速。静脉溶栓(IVT)预处理是否对ELVO患者功能预后有显著的影响仍不清楚。

方法:研究对所有评估血管内治疗(ET)对急性缺血性卒中的疗效的随机对照试验,进行了系统的综述和荟萃分析。研究者按照IVT预治疗进行分层,进行的混合效应亚组分析报告,对ET(与标准治疗)与3功能结果的相关性的OR值。

结果:纳入六项随机对照试验,包括1916例(49.1%接收ET 和IVT预治疗,5.6%接收ET治疗无IVT预治疗)患者。在亚组分析中,在IVT预治疗组(OR 1.83;95%CI,1.37-2.44;P<0.001)和非IVT治疗组(OR 2.47;95%CI,1.32-4.63;P = 0.001)中,ET与3个月良好功能预后相关。研究者记录IVT预治疗对行ET治疗的ELVO患者3功能预后无明显影响,提示ET对所有ELVO患者有效。IVT预处理组存在异质性(I(2)= 68.3%;Cochran Q = 0.014),未接受IVT预处理的亚组无异质性(I(2)= 0%, Cochran Q = 0.927)。对纳入试验进行定性评估发现,偏倚风险普遍较低。

结论:研究结果为临床治疗提供了依据,独立于IVT,ELVO患者接受ET治疗是有效的。

原始出处:

Tsivgoulis G, Katsanos AH, et al. Mechanical Thrombectomy Improves Functional Outcomes Independent of Pretreatment With Intravenous Thrombolysis. Stroke. 2016 Jun.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2009832, encodeId=b46c20098325c, content=<a href='/topic/show?id=467789803a9' target=_blank style='color:#2F92EE;'>#血管闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89803, encryptionId=467789803a9, topicName=血管闭塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Mar 24 07:26:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815188, encodeId=b9a3181518892, content=<a href='/topic/show?id=5f519e1848c' target=_blank style='color:#2F92EE;'>#闭塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97184, encryptionId=5f519e1848c, topicName=闭塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jun 15 04:26:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697334, encodeId=cbed169e334d6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Aug 30 01:26:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=145409, encodeId=aba8145409dd, content=好文值得点赞!继续关注学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Tue Oct 11 20:19:28 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706106, encodeId=01d01e061067a, content=<a href='/topic/show?id=7f6443986ec' target=_blank style='color:#2F92EE;'>#大血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43986, encryptionId=7f6443986ec, topicName=大血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caff31165455, createdName=kkunny, createdTime=Thu Sep 01 03:26:00 CST 2016, time=2016-09-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2009832, encodeId=b46c20098325c, content=<a href='/topic/show?id=467789803a9' target=_blank style='color:#2F92EE;'>#血管闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89803, encryptionId=467789803a9, topicName=血管闭塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Mar 24 07:26:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815188, encodeId=b9a3181518892, content=<a href='/topic/show?id=5f519e1848c' target=_blank style='color:#2F92EE;'>#闭塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97184, encryptionId=5f519e1848c, topicName=闭塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jun 15 04:26:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697334, encodeId=cbed169e334d6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Aug 30 01:26:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=145409, encodeId=aba8145409dd, content=好文值得点赞!继续关注学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Tue Oct 11 20:19:28 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706106, encodeId=01d01e061067a, content=<a href='/topic/show?id=7f6443986ec' target=_blank style='color:#2F92EE;'>#大血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43986, encryptionId=7f6443986ec, topicName=大血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caff31165455, createdName=kkunny, createdTime=Thu Sep 01 03:26:00 CST 2016, time=2016-09-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2009832, encodeId=b46c20098325c, content=<a href='/topic/show?id=467789803a9' target=_blank style='color:#2F92EE;'>#血管闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89803, encryptionId=467789803a9, topicName=血管闭塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Mar 24 07:26:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815188, encodeId=b9a3181518892, content=<a href='/topic/show?id=5f519e1848c' target=_blank style='color:#2F92EE;'>#闭塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97184, encryptionId=5f519e1848c, topicName=闭塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jun 15 04:26:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697334, encodeId=cbed169e334d6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Aug 30 01:26:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=145409, encodeId=aba8145409dd, content=好文值得点赞!继续关注学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Tue Oct 11 20:19:28 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706106, encodeId=01d01e061067a, content=<a href='/topic/show?id=7f6443986ec' target=_blank style='color:#2F92EE;'>#大血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43986, encryptionId=7f6443986ec, topicName=大血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caff31165455, createdName=kkunny, createdTime=Thu Sep 01 03:26:00 CST 2016, time=2016-09-01, status=1, ipAttribution=)]
    2016-08-30 fusion
  4. [GetPortalCommentsPageByObjectIdResponse(id=2009832, encodeId=b46c20098325c, content=<a href='/topic/show?id=467789803a9' target=_blank style='color:#2F92EE;'>#血管闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89803, encryptionId=467789803a9, topicName=血管闭塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Mar 24 07:26:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815188, encodeId=b9a3181518892, content=<a href='/topic/show?id=5f519e1848c' target=_blank style='color:#2F92EE;'>#闭塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97184, encryptionId=5f519e1848c, topicName=闭塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jun 15 04:26:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697334, encodeId=cbed169e334d6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Aug 30 01:26:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=145409, encodeId=aba8145409dd, content=好文值得点赞!继续关注学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Tue Oct 11 20:19:28 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706106, encodeId=01d01e061067a, content=<a href='/topic/show?id=7f6443986ec' target=_blank style='color:#2F92EE;'>#大血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43986, encryptionId=7f6443986ec, topicName=大血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caff31165455, createdName=kkunny, createdTime=Thu Sep 01 03:26:00 CST 2016, time=2016-09-01, status=1, ipAttribution=)]
    2016-10-11 ylzr123

    好文值得点赞!继续关注学习。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2009832, encodeId=b46c20098325c, content=<a href='/topic/show?id=467789803a9' target=_blank style='color:#2F92EE;'>#血管闭塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89803, encryptionId=467789803a9, topicName=血管闭塞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Mar 24 07:26:00 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815188, encodeId=b9a3181518892, content=<a href='/topic/show?id=5f519e1848c' target=_blank style='color:#2F92EE;'>#闭塞性卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97184, encryptionId=5f519e1848c, topicName=闭塞性卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Jun 15 04:26:00 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697334, encodeId=cbed169e334d6, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Tue Aug 30 01:26:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=145409, encodeId=aba8145409dd, content=好文值得点赞!继续关注学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Tue Oct 11 20:19:28 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706106, encodeId=01d01e061067a, content=<a href='/topic/show?id=7f6443986ec' target=_blank style='color:#2F92EE;'>#大血管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43986, encryptionId=7f6443986ec, topicName=大血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=caff31165455, createdName=kkunny, createdTime=Thu Sep 01 03:26:00 CST 2016, time=2016-09-01, status=1, ipAttribution=)]
    2016-09-01 kkunny

相关资讯

高颜值医生告诉你:肺癌不可怕 介入治疗精准杀死肿瘤

日前,荷兰传奇球星克鲁伊夫被确诊肺癌,尽管在确诊后克鲁伊夫表示自己对战胜病魔充满信心,但在大多数人心里,肺癌仍然是“谈之色变”的绝症 。肺癌在我国发病率、死亡率均位于第一,而且死亡率还在以每年4.45%的速度上升。不过,随着精准医疗时代的到来,很多新的诊疗方法极大提高了晚期肺癌患者的总生存期和生活质量。北京新里程肿瘤医院(北京大学肿瘤医院国际诊疗中心)影像介入诊疗中心主任柳晨是肺癌诊断和治疗方面的

2015长城会:杨毅宁教授:稳定性冠心病药物与介入治疗的选择

报告时间:11月1日 14:06~14:24 长城C2厅 稳定性冠心病(SCAD)是冠心病中最常见的类型,不仅包含稳定型劳力性心绞痛,还包括既往已明确的冠状动脉病变经治疗后症状消失、需定期随访的稳定患者以及有创或无创检查提示无症状缺血性心脏病患者。目前提出SCAD的诊断应进行“验前概率”评估,并依此选择适宜的诊断方案,不仅可以减少高危患者的漏诊,也可避免低危患者接受不必要的检查、减轻医疗

心脏支架的历史

冠状动脉介入治疗(PercutaneousCoronaryIntervention,简称PCI),也就是老百姓常说的“放支架”。由于冠状动脉的直径仅有2~4毫米,介入治疗用的导管也仅有2毫米左右,它常被医生比喻为“在针尖上跳舞”。虽然PCI的发展历史不过30多年,却始终充满了崎岖、坎坷,甚至冷遇和嘲讽,医学先贤们靠着坚韧不拔的探索精神才得以发展至今。

中国颅脑疾病介入治疗麻醉管理专家共识

中国颅脑疾病介入治疗麻醉管理专家共识 中华医学会麻醉学分会神经外科麻醉学组 颅脑疾病介入治疗包括颅内动脉瘤、颅脑动静脉畸形、急性缺血性脑卒中和颈动脉狭窄介入治疗及帕金森病脑深部电刺激术。本专家共识旨在提高中国颅脑疾病介入治疗麻醉管理水平,降低围手术期相关并发症,并改善患者术后转归。由于该领域循证医学证据有限,临床实践中需根据患者具体情况,参照本专家共识实施个体化麻醉

院士讲的这几条,当下有多少医生做得到

介入治疗、药物治疗是最常见的冠心病治疗方式,那么百姓应该如何正确选择药物?介入治疗前后又有哪些用药注意事项?

Lancet:老年非ST段抬高型心肌梗死或不稳定型心绞痛患者:介入治疗优于保守治疗

非ST段抬高心肌梗死(NSTEMI)和不稳定心绞痛是在老年人入院的常见原因。然而,针对这部分人群的临床试验是稀缺的,而这些病人不太可能按照指南接受治疗。该研究的目的是调查这个人群是否会受益于早期介入治疗 vs 保守策略。原始出处:Nicolai Tegn, Michael Abdelnoor,Lars Aaberge,et al.Invasive versus conservative strat